Lv1
50 积分 2022-12-28 加入
Lipid nanoparticles produce chimeric antigen receptor macrophages (CAR-M) in situ for the treatment of solid tumors
20天前
已完结
Lipid nanoparticles produce chimeric antigen receptor T cells with interleukin-6 knockdown in vivo
20天前
已完结
In Vivo CD19 CAR T-Cell Therapy for Refractory Systemic Lupus Erythematosus
20天前
已完结
In vivo generation of anti-BCMA CAR-T cells in relapsed or refractory multiple myeloma: a phase 1 study
20天前
已完结
In vivo chimeric antigen receptor (CAR)-T cell therapy
21天前
已完结
In vivo CAR T cell engineering: design principles and open questions
25天前
已完结
Dendritic-cell-targeting virus-like particles as potent mRNA vaccine carriers
1个月前
已完结
Erythrocyte–anti-PD1 conjugates in persons with advanced solid tumors resistant to anti-PD1/PDL1: preclinical characterization and results of a phase 1 trial
1个月前
已完结
Pluripotent stem cell-derived CAR-NK progenitor therapy targets minimal residual disease and prevents relapse in leukemia models
1个月前
已完结
Comprehensive Human Proteome Profiles Across a 50-Year Lifespan Reveal Aging Trajectories and Signatures
3个月前
已完结
皖公网安备34019202002308
